BRPI0111220B1 - conjugados de fármacos com etilenodicisteína (ec) - Google Patents
conjugados de fármacos com etilenodicisteína (ec)Info
- Publication number
- BRPI0111220B1 BRPI0111220B1 BRPI0111220A BR0111220A BRPI0111220B1 BR PI0111220 B1 BRPI0111220 B1 BR PI0111220B1 BR PI0111220 A BRPI0111220 A BR PI0111220A BR 0111220 A BR0111220 A BR 0111220A BR PI0111220 B1 BRPI0111220 B1 BR PI0111220B1
- Authority
- BR
- Brazil
- Prior art keywords
- drug conjugates
- ethylenedicistein
- chelated
- specific
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"conjugados de fármacos de etilenodicisteína (ec)". a invenção fornece, num sentido geral, uma nova estratégia de rotulação com emprego de 99tc quelado com etilenodicisteína (ec). ec é conjugada com uma variedade de ligantes e quelada ao ^ 99m^tc para uso em um agente de geração de imagem para doenças específicas de tecido. os conjugados do fármaco da invenção podem também ser usados como uma ferramenta de prognóstico ou como uma ferramenta para entregar compostos terapêuticos a sítios específicos num corpo de mamífero. estojos para uso na geração de imagem de doenças específicas de tecido são também providos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58758300A | 2000-06-02 | 2000-06-02 | |
US09/599,152 US7067111B1 (en) | 1999-10-25 | 2000-06-21 | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
PCT/US2001/018060 WO2001091807A2 (en) | 2000-06-02 | 2001-06-01 | Ethylenedicysteine (ec)-drug conjugates |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0111220A BR0111220A (pt) | 2003-06-24 |
BRPI0111220B1 true BRPI0111220B1 (pt) | 2016-10-11 |
BRPI0111220B8 BRPI0111220B8 (pt) | 2021-07-27 |
Family
ID=27080078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0111220A BRPI0111220B8 (pt) | 2000-06-02 | 2001-06-01 | conjugados de fármacos com etilenodicisteína (ec) |
Country Status (16)
Country | Link |
---|---|
US (4) | US7615208B2 (pt) |
EP (2) | EP1286704B1 (pt) |
JP (3) | JP5448284B2 (pt) |
KR (1) | KR100784120B1 (pt) |
CN (1) | CN1292798C (pt) |
AU (2) | AU2001275210B2 (pt) |
BR (1) | BRPI0111220B8 (pt) |
CA (1) | CA2410906C (pt) |
DK (1) | DK1286704T3 (pt) |
ES (1) | ES2518926T3 (pt) |
HK (1) | HK1056682A1 (pt) |
HU (1) | HU230437B1 (pt) |
IL (2) | IL153218A0 (pt) |
NO (1) | NO332574B1 (pt) |
PL (1) | PL212211B1 (pt) |
WO (1) | WO2001091807A2 (pt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
JP5448284B2 (ja) * | 2000-06-02 | 2014-03-19 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | エチレンジシステイン(ec)−薬物結合体 |
CA2443314C (en) * | 2001-04-03 | 2006-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of imaging cell death in vivo |
KR20040015234A (ko) | 2001-05-02 | 2004-02-18 | 펄듀 리서치 파운데이션 | 대식세포 매개된 질환의 치료와 진단 |
US7261875B2 (en) | 2001-12-21 | 2007-08-28 | Board Of Regents, The University Of Texas System | Dendritic poly (amino acid) carriers and methods of use |
US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
US8043603B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
JP4360917B2 (ja) * | 2002-02-26 | 2009-11-11 | 株式会社バイオメッドコア | リポソームへの金属錯体の封入方法 |
US7381399B2 (en) * | 2002-03-11 | 2008-06-03 | Molecular Insight Pharmaceuticals, Inc. | Technetium-dipyridine complexes, and methods of use thereof |
US7824661B2 (en) | 2002-03-11 | 2010-11-02 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
DK2260875T3 (da) * | 2002-05-06 | 2014-06-30 | Endocyte Inc | Folatreceptor-targetede billeddannelsesmidler |
CN1723042B (zh) * | 2002-11-07 | 2010-12-01 | 得克萨斯大学体系董事会 | 乙二半胱氨酸(ec)-药物结合物、组合物及用于组织特异性疾病显像的方法 |
CN100381177C (zh) * | 2003-01-27 | 2008-04-16 | 恩多塞特公司 | 维生素受体结合递药缀合物 |
US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
AU2005215510A1 (en) | 2004-02-12 | 2005-09-01 | Molecular Insight Pharmaceuticals, Inc. | Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
WO2005087275A2 (en) * | 2004-03-11 | 2005-09-22 | Board Of Regents, The University Of Texas System | Metal radiolabeled pet imaging agents |
CA2592302C (en) * | 2004-12-23 | 2013-10-29 | Purdue Research Foundation | Positron emission tomography imaging method |
AU2006232318A1 (en) * | 2005-04-01 | 2006-10-12 | The Board Of Regents Of The University Of Texas System | Poly(peptide) as a chelator: methods of manufacture and uses |
JP5175723B2 (ja) | 2005-07-05 | 2013-04-03 | パーデュー・リサーチ・ファウンデーション | 単球介在性疾患を治療するための組成物の調製 |
US10925977B2 (en) * | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
EP2087337A4 (en) | 2006-11-03 | 2010-09-08 | Purdue Research Foundation | METHOD AND DEVICE FOR EX-VIVO FLOW CYTOMETRY |
WO2008064040A2 (en) * | 2006-11-22 | 2008-05-29 | The Board Of Regents Of The University Of Texas System | Methods and compositions using chelator-antibody conjugates |
EP2109466B1 (en) | 2007-02-07 | 2014-11-12 | Purdue Research Foundation | Positron emission tomography imaging method |
BRPI0809442A2 (pt) * | 2007-03-27 | 2014-09-09 | Radiomedix Inc | Composições para terapia e formação de imagens direcionada |
WO2008148001A2 (en) | 2007-05-25 | 2008-12-04 | Purdue Research Foundation | Method of imaging localized infections |
CA2719623A1 (en) * | 2008-03-24 | 2009-10-01 | The Board Of Regents Of The University Of Texas System | Image-guided therapy of myocardial disease: composition, manufacturing and applications |
CN101721720B (zh) | 2008-10-29 | 2011-08-24 | 阮建评 | 硝咪唑-氨基酸化合型核素乏氧造影剂及其前体 |
WO2011044377A2 (en) * | 2009-10-09 | 2011-04-14 | Cell Point, Llc | Chelator-targeting ligand conjugates for cardiovascular imaging |
US20110280770A1 (en) * | 2010-05-12 | 2011-11-17 | Jeffrey Lacy | Nanogenerator |
CA2843313C (en) | 2011-06-20 | 2018-02-13 | Radiomedix Inc. | Compositions, methods of synthesis and use of carbohydrate targeted agents |
PL2830666T3 (pl) * | 2012-03-26 | 2021-03-08 | Board Of Regents, The University Of Texas System | Skuteczna synteza koniugatów etylenodicysteina-cukier do obrazowania i terapii |
US9886546B2 (en) | 2012-11-20 | 2018-02-06 | General Electric Company | Methods and apparatus to label radiology images |
CN108514646B (zh) * | 2013-11-14 | 2021-07-16 | 恩多塞特公司 | 用于正电子发射断层术的化合物 |
ES2811347T3 (es) | 2015-08-14 | 2021-03-11 | Endocyte Inc | Método de formación de imágenes con un compuesto quelante |
US10905783B2 (en) | 2015-11-27 | 2021-02-02 | Michal RIVLIN | Glucosamine and derivatives thereof in imaging |
CN111372940A (zh) * | 2017-09-19 | 2020-07-03 | 阿尔伯塔大学理事会 | 生物还原活化的化合物、其前药、放射性药物、组合物及其在包括癌症在内的低氧疾病的多模式治疗控制中的应用 |
RU2692451C2 (ru) * | 2017-10-02 | 2019-06-24 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр" Российской академии наук ("Томский НИМЦ") | Способ радионуклидной диагностики опухолей головного мозга |
WO2019123409A1 (en) * | 2017-12-21 | 2019-06-27 | University Of The Free State | Multinuclear complexes and their preparation |
CN112672762A (zh) * | 2018-07-26 | 2021-04-16 | 普渡研究基金会 | 用于抗流感化学治疗和免疫治疗的小分子配体靶向药物缀合物 |
CN113041366A (zh) * | 2021-03-12 | 2021-06-29 | 青岛大学附属医院 | 一种新型肿瘤乏氧正电子显像剂及其制备方法 |
Family Cites Families (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141654A (en) | 1977-05-23 | 1979-02-27 | James V. Massey, III | Standard for calibrating and/or verifying instrument accuracy |
US4279992A (en) | 1978-03-13 | 1981-07-21 | Miles Laboratories, Inc. | Specific binding assay employing an enzyme-cleavable substrate as label |
US4181654A (en) | 1978-07-24 | 1980-01-01 | The United States Of America As Represented By The United States Department Of Energy | 2,3-Dihydroxybenzoic acid amides of tetraazaalkanes and tetaaza cycloalkanes |
US4418068A (en) | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US5648063A (en) | 1981-07-24 | 1997-07-15 | Schering Aktiengesellschaft | Sterile composition comprising a chelate complex for magnetic resonance imaging |
US4737550A (en) | 1983-01-07 | 1988-04-12 | The Dow Chemical Company | Bridged dense star polymers |
US4507466A (en) | 1983-01-07 | 1985-03-26 | The Dow Chemical Corporation | Dense star polymers having core, core branches, terminal groups |
US4558120A (en) | 1983-01-07 | 1985-12-10 | The Dow Chemical Company | Dense star polymer |
US4568737A (en) | 1983-01-07 | 1986-02-04 | The Dow Chemical Company | Dense star polymers and dendrimers |
US4631337A (en) | 1983-01-07 | 1986-12-23 | The Dow Chemical Company | Hydrolytically-stable dense star polyamine |
US4587329A (en) | 1984-08-17 | 1986-05-06 | The Dow Chemical Company | Dense star polymers having two dimensional molecular diameter |
US4732863A (en) | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
US5242679A (en) | 1985-01-14 | 1993-09-07 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US4824659A (en) | 1985-06-07 | 1989-04-25 | Immunomedics, Inc. | Antibody conjugates |
GB8525974D0 (en) | 1985-10-22 | 1985-11-27 | Nyegaard & Co As | Chemical substance |
US4871779A (en) | 1985-12-23 | 1989-10-03 | The Dow Chemical Company | Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities |
MX174467B (es) | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
US4694064A (en) | 1986-02-28 | 1987-09-15 | The Dow Chemical Company | Rod-shaped dendrimer |
US4789542A (en) | 1986-04-29 | 1988-12-06 | The United States Of America As Represented By The United States Department Of Energy | Radioiodinated glucose analogues for use as imaging agents |
US4861869A (en) | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
US4713975A (en) | 1986-05-30 | 1987-12-22 | The Dow Chemical Company | Dense star polymers for calibrating/characterizing sub-micron apertures |
IN165717B (pt) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
US4730968A (en) | 1986-09-08 | 1988-03-15 | David Diperstein | Self-tapping, self-aligning thread repair insert |
US5279811A (en) | 1987-02-18 | 1994-01-18 | The Du Pont Merck Pharmaceutical Company | Ester-substituted diaminedithiols and radiolabeled complexes thereof |
US4965392A (en) | 1987-03-26 | 1990-10-23 | Neorx Corporation | Chelating compounds for metal-radionuclide labeled proteins |
US4857599A (en) | 1988-02-08 | 1989-08-15 | The Dow Chemical Company | Modified dense star polymers |
US5164294A (en) | 1988-05-17 | 1992-11-17 | Syntex (U.S.A.) Inc. | Method for immunochromatographic analysis |
US4988496A (en) | 1988-05-31 | 1991-01-29 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5071965A (en) | 1988-07-19 | 1991-12-10 | Mallinckrodt Medical, Inc. | Novel tc-99m complexes |
US4925650A (en) | 1988-11-16 | 1990-05-15 | Mallinckrodt, Inc. | Technetium -99m complex for examining the renal function |
US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
US5688488A (en) | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
JP2517760B2 (ja) | 1989-05-11 | 1996-07-24 | 新技術事業団 | 水溶性高分子化医薬製剤 |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5356793A (en) | 1990-03-15 | 1994-10-18 | Nitta Gelatin Inc. | Method for testing the sensitivity of anticancer drug |
JP3005943B2 (ja) | 1990-04-17 | 2000-02-07 | マリンクロッド・インコーポレイテッド | テクネチウム―99m錯化合物製造のための方法及びキット |
EP0548245A1 (en) * | 1990-06-18 | 1993-06-30 | Mallinckrodt Medical, Inc. | Metal-radionuclide complex comprising isonitrile ligands |
US5385719A (en) | 1991-09-24 | 1995-01-31 | Unger; Evan C. | Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
US5808091A (en) | 1991-10-29 | 1998-09-15 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia localizing moiety |
US5601800A (en) | 1991-11-08 | 1997-02-11 | Curators Of The University Of Missouri | New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents |
US5310536A (en) | 1992-02-06 | 1994-05-10 | Mallinckrodt Medical, Inc. | Ligands for improving metal chelate formation kinetics |
US5877289A (en) | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US6033884A (en) | 1992-03-20 | 2000-03-07 | Baylor College Of Medicine | Nucleic acid transporter systems and methods of use |
US6113946A (en) | 1992-04-03 | 2000-09-05 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system comprising dendrimer polycations |
US5541287A (en) | 1992-06-09 | 1996-07-30 | Neorx Corporation | Pretargeting methods and compounds |
ATE210464T1 (de) | 1992-06-09 | 2001-12-15 | Neorx Corp | BIOTIN-DOTA KONJUGATE UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN |
US5716596A (en) | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
US5496533A (en) * | 1992-07-31 | 1996-03-05 | Australian Nuclear Science & Technology Organisation | Rhenium complexes |
US5605671A (en) | 1992-10-05 | 1997-02-25 | The Regents Of The University Of Michigan | Radiolabeled neutrophil activating peptides for imaging |
US5834266A (en) | 1993-02-12 | 1998-11-10 | President & Fellows Of Harvard College | Regulated apoptosis |
US5951964A (en) | 1993-06-04 | 1999-09-14 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
US5605672A (en) | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
US5534241A (en) | 1993-07-23 | 1996-07-09 | Torchilin; Vladimir P. | Amphipathic polychelating compounds and methods of use |
US5449761A (en) | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
JPH07126165A (ja) * | 1993-10-29 | 1995-05-16 | Masao Oguro | 腫瘍治療剤 |
US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
WO1995026206A1 (en) | 1994-03-28 | 1995-10-05 | The Regents Of The University Of California | Method for preparing radionuclide-labeled chelating agent-ligand complexes |
US5730968A (en) | 1994-03-31 | 1998-03-24 | Sterling Winthrop Inc. | Segmented chelating polymers as imaging and therapeutic agents |
US5670132A (en) | 1994-09-20 | 1997-09-23 | Immunomedics, Inc. | Modified radioantibody fragments for reduced renal uptake |
US6232295B1 (en) | 1994-10-12 | 2001-05-15 | Jon Faiz Kayyem | Cell-specific contrast agent and gene delivery vehicles |
US6083741A (en) | 1994-11-17 | 2000-07-04 | Imperial College Of Science Technology And Medicine | Internalisation of DNA, using conjugates of poly-l-lysine and an integrin receptor ligand |
US5643883A (en) | 1995-01-19 | 1997-07-01 | Uab Research Foundation | Glucose-6-phosphate uptake inhibitors and novel uses thereof |
US5955605A (en) | 1995-02-21 | 1999-09-21 | Neorx Corporation | Biotinidase resistant biotin-DOTA conjugates |
US5830431A (en) | 1995-06-07 | 1998-11-03 | Mallinckrodt Medical, Inc. | Radiolabeled peptide compositions for site-specific targeting |
US5908777A (en) | 1995-06-23 | 1999-06-01 | University Of Pittsburgh | Lipidic vector for nucleic acid delivery |
JP3543201B2 (ja) * | 1995-10-03 | 2004-07-14 | 日本ペイント株式会社 | 熱硬化性樹脂粒子の製造方法 |
US5739313A (en) | 1995-11-13 | 1998-04-14 | Regents Of The University Of Minnesota | Radionuclide labeling of vitamin B12 and coenzymes thereof |
JP3737518B2 (ja) | 1996-03-12 | 2006-01-18 | ピージー−ティーエックスエル カンパニー, エル.ピー. | 水溶性パクリタキセルプロドラッグ |
US6441025B2 (en) | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
JP3963996B2 (ja) * | 1996-03-28 | 2007-08-22 | 日本メジフィジックス株式会社 | 糖代謝機能診断剤 |
US5986074A (en) | 1996-05-06 | 1999-11-16 | Emory University | Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof |
US5955053A (en) | 1996-05-06 | 1999-09-21 | Emory University | Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof |
IT1284046B1 (it) | 1996-06-21 | 1998-05-08 | Bracco Spa | Processo per la preparazione di tetraazamacrocicli |
US5900228A (en) | 1996-07-31 | 1999-05-04 | California Institute Of Technology | Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye |
TW520297B (en) | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
DK0956001T3 (da) | 1996-11-12 | 2012-10-22 | Univ California | Fremstilling af stabile formuleringer af lipid-nukleinsyre-komplekser til virksom in-vivo indgivelse |
WO1998026912A1 (fr) * | 1996-12-18 | 1998-06-25 | Toray Industries, Inc. | Pre-impregne de fibres de carbone |
US6187286B1 (en) | 1996-12-27 | 2001-02-13 | The General Hospital Corporation | Tumor imaging agents, methods and kits |
US6005083A (en) | 1997-03-28 | 1999-12-21 | Neorx Corporation | Bridged aromatic substituted amine ligands with donor atoms |
EP0879606A1 (en) * | 1997-04-25 | 1998-11-25 | Paul Scherrer Institut | Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
TW541184B (en) | 1997-04-30 | 2003-07-11 | Univ Leland Stanford Junior | Use of annexin for imaging cell death in vivo |
JP3794517B2 (ja) * | 1997-05-08 | 2006-07-05 | 日本メジフィジックス株式会社 | 腫瘍診断剤 |
US6251866B1 (en) | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
US20030013772A1 (en) | 2000-02-23 | 2003-01-16 | Murphy Michael A. | Composition, synthesis and therapeutic applications of polyamines |
US6713046B1 (en) | 1997-10-27 | 2004-03-30 | Research Corporation Technologies | Magnetic resonance imaging agents for the delivery of therapeutic agents |
ATE397063T1 (de) * | 1997-11-25 | 2008-06-15 | Genentech Inc | Fibroblasten-wachstumsfaktor-19 |
US6071490A (en) | 1998-05-07 | 2000-06-06 | Immunomedics, Inc. | Position emission tomography using gallium-68 chelates |
AU4317399A (en) | 1998-05-28 | 1999-12-13 | Parker Hughes Institute | Quinazolines for treating brain tumor |
IT1302125B1 (it) | 1998-08-03 | 2000-07-31 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide |
US20010041189A1 (en) | 1999-04-13 | 2001-11-15 | Jingya Xu | Poly(dipeptide) as a drug carrier |
US7067111B1 (en) * | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
US6692724B1 (en) | 1999-10-25 | 2004-02-17 | Board Of Regents, The University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
DE10024874A1 (de) | 2000-05-16 | 2001-11-29 | Siemens Ag | Polierflüssigkeit und Verfahren zur Strukturierung von Metallen und Metalloxiden |
JP5448284B2 (ja) * | 2000-06-02 | 2014-03-19 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | エチレンジシステイン(ec)−薬物結合体 |
US6656450B2 (en) | 2000-07-17 | 2003-12-02 | California Institute Of Technology, Inc. | Macrocyclic magnetic resonance imaging contrast agents |
US6440389B1 (en) | 2000-07-19 | 2002-08-27 | The General Hospital Corporation | Fluorescent agents for real-time measurement of organ function |
AU2002220082A1 (en) | 2000-10-19 | 2002-04-29 | The General Hospital Corporation | Imaging of enzymatic activity |
JP2002241307A (ja) | 2001-02-19 | 2002-08-28 | Yasuhiko Tabata | 光増感剤を含有する超音波治療用活性酸素発生剤 |
DE10135355C1 (de) | 2001-07-20 | 2003-04-17 | Schering Ag | Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie |
US20030152512A1 (en) | 2001-11-13 | 2003-08-14 | Milind Rajopadhye | Imaging thrombus with glycoprotein llb/llla antagonists |
US7261875B2 (en) | 2001-12-21 | 2007-08-28 | Board Of Regents, The University Of Texas System | Dendritic poly (amino acid) carriers and methods of use |
US7121926B2 (en) | 2001-12-21 | 2006-10-17 | Micron Technology, Inc. | Methods for planarization of group VIII metal-containing surfaces using a fixed abrasive article |
-
2001
- 2001-06-01 JP JP2001587819A patent/JP5448284B2/ja not_active Expired - Lifetime
- 2001-06-01 ES ES01941895.3T patent/ES2518926T3/es not_active Expired - Lifetime
- 2001-06-01 EP EP01941895.3A patent/EP1286704B1/en not_active Expired - Lifetime
- 2001-06-01 IL IL15321801A patent/IL153218A0/xx unknown
- 2001-06-01 DK DK01941895.3T patent/DK1286704T3/da active
- 2001-06-01 CA CA2410906A patent/CA2410906C/en not_active Expired - Lifetime
- 2001-06-01 AU AU2001275210A patent/AU2001275210B2/en not_active Expired
- 2001-06-01 AU AU7521001A patent/AU7521001A/xx active Pending
- 2001-06-01 WO PCT/US2001/018060 patent/WO2001091807A2/en active Application Filing
- 2001-06-01 KR KR1020027016455A patent/KR100784120B1/ko active IP Right Grant
- 2001-06-01 CN CNB018116051A patent/CN1292798C/zh not_active Expired - Lifetime
- 2001-06-01 HU HU0300951A patent/HU230437B1/hu unknown
- 2001-06-01 PL PL359337A patent/PL212211B1/pl not_active IP Right Cessation
- 2001-06-01 BR BRPI0111220A patent/BRPI0111220B8/pt not_active IP Right Cessation
- 2001-06-01 EP EP10181884A patent/EP2316494A1/en not_active Withdrawn
-
2002
- 2002-11-28 NO NO20025729A patent/NO332574B1/no not_active IP Right Cessation
- 2002-12-02 IL IL153218A patent/IL153218A/en active IP Right Grant
-
2003
- 2003-12-11 HK HK03109030A patent/HK1056682A1/xx not_active IP Right Cessation
-
2007
- 2007-06-08 US US11/760,456 patent/US7615208B2/en not_active Expired - Fee Related
-
2008
- 2008-05-09 JP JP2008123946A patent/JP2008208138A/ja not_active Withdrawn
-
2009
- 2009-09-21 US US12/563,724 patent/US8236279B2/en not_active Expired - Lifetime
-
2012
- 2012-07-11 JP JP2012155112A patent/JP5781026B2/ja not_active Expired - Lifetime
- 2012-07-18 US US13/552,414 patent/US20130165631A1/en not_active Abandoned
-
2014
- 2014-01-24 US US14/163,434 patent/US20140200329A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0111220B1 (pt) | conjugados de fármacos com etilenodicisteína (ec) | |
BR0014652A (pt) | Fabricação de conjugados de agente terapêutico-poliglutamato | |
BR0110767A (pt) | Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina | |
BR0109107A (pt) | Usos terapêuticos de mediadores ppar | |
AU3694901A (en) | A parasiticidal formulation and a method of making this formulation | |
BRPI0011856B8 (pt) | agonistas de receptor a2a de n-pirazol | |
BR0010478A (pt) | Vacina de célula total contendo antìgeno de staphyloccocus aureus | |
BR0113524A (pt) | Composição antiperspirante e/ou desodorante sólida | |
BR0206985A (pt) | Anticorpos modificados e métodos de uso | |
BR0014512A (pt) | Tratamento tópico para infecções por estreptococos | |
BR0015194A (pt) | Uso de um inibidor de egfr-tirosina-quinase, e, métodos para redução da transformação de células epiteliais e para causar reversão substancial de tecido epitelial | |
WO2006053172A3 (en) | The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases | |
IL127965A0 (en) | Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same | |
BR9808422A (pt) | Composto, composição farmacêutica, processos para induzir paralisia neuromuscular em um mamìfero e para a preparação de um composto, e, uso de um composto | |
BR0103256A (pt) | Utilização de substâncias bioquìmicas para uma composição para a prevenção e tratamento de condições de saúde causadas por constrição de células de músculo liso em órgãos do corpo humano | |
AU5076799A (en) | Trifunctional reagent for conjugation to a biomolecule | |
BR0210720A (pt) | Composto e uso do mesmo | |
BR0109280A (pt) | Artigo absorvente para ser usado por um usuário adjacente à pele e processo para produzir o mesmo | |
BRPI0401758A (pt) | Composição farmacêutica analgésica tópica, luva, e, métodos para aplicar uma luva a uma extremidade humana com uma área afetada, para preparar uma luva, e para aperfeiçoar uma função de junta | |
GB9610971D0 (en) | A diagnostic test for use in schizophrenia | |
BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
BR9809785A (pt) | Composto de ligação de receptor de calcitonina, reagente, agente de formação de imagem cintigráfica, composição, agente radio-terapêutico, complexo, kit para preparar uma preparação radio-farmacêutica, processos para rotular o reagente, para fabricar o reagente, e, uso do reagente | |
ATE220912T1 (de) | Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung | |
EP0337746A3 (en) | Composition for enhancing the biodistribution of antibody for localization in lesions | |
BR9912816A (pt) | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/12/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/06/2001, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 01/06/2021 |